How Ph.D. was paid
$6.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| John Houston, Ph.D.Former President and Chief Executive Officer | $706,236 | $2,685,840 | $2,671,051 | $457,000 | $14,000 | $6,534,127 |
| Andrew SaikChief Financial Officer and Treasurer | $542,063 | $1,261,412 | $1,281,339 | $263,500 | $14,000 | $3,362,314 |
| Noah Berkowitz, M.D., Ph.D.Chief Medical Officer | $552,387 | $1,369,852 | $1,389,217 | $268,500 | $14,000 | $3,593,956 |
| Angela Cacace, Ph.D.Chief Scientific Officer | $500,763 | $1,261,412 | $1,281,339 | $243,400 | $14,000 | $3,300,914 |
| Ian Taylor, Ph.D.Former President of Research and Development | $152,567 | $364,338 | $362,468 | — | $24,016 | $903,389 |
What changed and why
- $6.5MFormer CEO John Houston received total compensation of $6,534,127 for fiscal 2025, representing a decrease from the prior year.
- 3.25%Named executive officers received annual base salary merit adjustments of 3.25% in February 2025.
- 108.0%Corporate goal achievement for 2025 was determined to be 108.0% after funding a special bonus pool for non-executive employees.
- $680KRandy Teel was appointed President and Chief Executive Officer in February 2026 with a base salary of $680,000.
- 75%Stockholders approved the prior say-on-pay proposal with approximately 75% support at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.